v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Equity
Additional Paid in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   54,440,013      
Beginning balance at Dec. 31, 2024 $ 491,875 $ 7 $ 712,884   $ (221,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   88,962      
Issuance of common stock upon exercise of stock options 477   477    
Stock-based compensation 3,451   3,451    
Net loss (36,846)       (36,846)
Ending balance (in shares) at Mar. 31, 2025   54,528,975      
Ending balance at Mar. 31, 2025 $ 458,957 $ 7 716,812   (257,862)
Beginning balance (in shares) at Dec. 31, 2025 56,600,724 56,600,724      
Beginning balance at Dec. 31, 2025 $ 401,452 $ 7 760,168 $ 243 (358,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, and accompanying pre-funded warrants, net of offering cost (in shares)   8,581,250      
Issuance of common stock, and accompanying pre-funded warrants, net of issuance cost $ 161,763 $ 1 161,762    
Issuance of common stock upon exercise of stock options (in shares) 366,416 365,063      
Issuance of common stock upon exercise of stock options $ 1,582   1,582    
Stock-based compensation 5,858   5,858    
Unrealized loss on marketable securities, net of tax (486)     (486)  
Net loss $ (56,211)       (56,211)
Ending balance (in shares) at Mar. 31, 2026 65,547,037 65,547,037      
Ending balance at Mar. 31, 2026 $ 513,958 $ 8 $ 929,370 $ (243) $ (415,177)